ScholarIQanswers from OpenAlex & ORCID
Shitij Kapur
ResearcherPublications, citations & collaboration network
Shitij Kapur is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Shitij Kapur have?
ScholarIQindexed works
Shitij Kapur has 914 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Shitij Kapur have?
ScholarIQcitation count
Shitij Kapur has 56,292 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Shitij Kapur?
ScholarIQh-index
Shitij Kapur has an h-index of 115 in OpenAlex.
What is the i10-index of Shitij Kapur?
ScholarIQi10-index
Shitij Kapur has an i10-index of 376 in OpenAlex.
What is the ORCID of Shitij Kapur?
ScholarIQorcid
The ORCID for Shitij Kapur is on the source record.
What is the OpenAlex record for Shitij Kapur?
ScholarIQopenalex
The OpenAlex for Shitij Kapur is on the source record.
What are the most-cited papers on Shitij Kapur?
ScholarIQmost cited works
Grand challenges in global mental health
Pamela Y. Collins, Vikram Patel, Sarah S. Joestl, Dana March, Thomas R. Insel, Abdallah S. Daar, Isabel A. Bordin, E. Jane Costello, Maureen S. Durkin, Christopher Fairburn, Roger I. Glass, Wayne Hall, Yueqin Huang, Steven E. Hyman, Kay Redfield Jamison, Sylvia Kaaya, Shitij Kapur, Arthur Kleinman, Adesola Ogunniyi, Angel A. Otero-Ojeda, Mu‐ming Poo, Vijayalakshmi Ravindranath, Barbara J. Sahakian, Shekhar Saxena, Peter Singer, Dan J. Stein, Warwick P. Anderson, Muhammad A. Dhansay, Wendy Ewart, Anthony G. Phillips, Susan B. Shurin, Mark Walport
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya, Paul D. Morrison, Paolo Fusar‐Poli, Rocío Martín‐Santos, Stefan Borgwardt, Toby Winton‐Brown, Chiara Nosarti, Colin M O' Carroll, Marc L. Seal, Paul Allen, Mitul A. Mehta, James Stone, Nigel Tunstall, Vincent Giampietro, Shitij Kapur, Robin Murray, Antônio Waldo Zuardi, José Alexandre S. Crippa, Zerrin Atakan, Philip McGuire
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
René S. Kahn, René S Kahn, Inge Winter van Rossum, Stefan Leucht, Philip McGuire, Shon W Lewis, Marion Leboyer, Celso Arango, Paola Dazzan, Richard Drake, Stephan Heres, Covadonga M Díaz-Caneja, Dan Rujescu, Mark Weiser, Silvana Galderisi, Birte Glenthøj, Marinus J C Eijkemans, W. Wolfgang Fleischhacker, Shitij Kapur, Iris E. Sommer, René S Kahn, René S Kahn, Iris E. Sommer, Inge Winter-van Rossum, Metten Somers, Paula C Ywema, Shitisj Kapur, Philip McGuire, Marion Leboyer, Andreas Meyer‐Lindenberg, Shôn Lewis, Stefan Leucht, Celso Arango, Wolfgang Fleischhacker, Anne Lotte Meijering, Jocelyn Petter, Resy van de Brug, Joost Schotsman, Jildou Zwerver, Jos Peuskens, Marc De Hert, E Thys, Lucho G Hranov, Valentin Hranov, Jan Libiger, Richard M. Köhler, Pavel Mohr, Birte Glenthoj, Brian V. Broberg, Signe Wegmann Düring, Lone Baandrup, Stephane Jamain, Stephan Heres, Dan Rujescu, Ina Giegling, Mark Weiser, Mor Bar Heim, Michael Davidson, Silvana Galderisi, Paola Bucci, Armida Mucci, Janusz Rybakowski, Agnieszka Remlinger-Molenda, Ilan Gonen, Paull Radu, Marina Díaz‐Marsá, Roberto Rodríguez–Jiménez, Tomas Palomo, Roberto Rodriguez-Jimenez, Paz García-Portilla, Miquel Bernardo, Julio Bobes, Christina Vilares Oliveira, Gregor Berger, Claudia Wildt, Paola Dazzan, Roccio Perez-Iglesias, Richard Drake, Sarah Gregory, Danielle Wilson, Covadonga M. Díaz‐Caneja, Marinus J.C. Eijkemans